Core Viewpoint - Koninklijke Philips NV shares experienced a significant decline, marking the largest single-day drop since February, following cautious remarks from CEO Roy Jakobs at Citi's Global Healthcare Conference [1][2]. Group 1: Company Performance and Outlook - Philips anticipates organic sales growth to improve from 2% this year to 2026, but is "unlikely" to meet the 4.5% consensus forecast [2]. - The company reiterated its goal to enhance margins by 2026, although it warned that tariff headwinds are expected to nearly double next year [3]. - Philips expects comparative sales growth to accelerate towards mid-single-digit growth in 2026, supported by solid order momentum [6]. Group 2: Financial Results - For the third quarter of 2025, Philips reported adjusted earnings per share of 42 cents (0.36 euros), surpassing the consensus estimate of 37 cents [7]. - The company recorded quarterly sales of $5.03 billion (4.302 billion euros), aligning with market expectations [7]. Group 3: Market Conditions - The global hospital capital spending environment in 2026 is expected to be similar to 2025, with strong demand in the U.S. and solid performance in Europe and international markets, while conditions in China remain muted [4].
Philips CEO Warns About 2026 Growth Target, Stock Drops